Withdrawn ID: | w242 |
---|---|
Canonical SMILES: | |
Standard InChI: | |
Standard InChIKey: | |
ATC class(es): | R03AB03 |
R03CB03 | |
R03CB53 | |
Molecular Formula: | C11H17NO3 |
Molweight: | 211.258 |
Withdrawn due to drug safety reasons: | Yes |
---|---|
First approved: | 2003 |
First withdrawn: | 2009 |
Last withdrawn: | 2009 |
Reference: | https://www.ncbi.nlm.nih.gov/pubmed/23920058 |
Total reported cases (submitted by medical professionals) with Orciprenaline as primary suspect: | 10 |
---|
Hospitalization (initial or prolonged): | 5 |
---|---|
Life-Threatening condition: | 3 |
Disability: | 1 |
Intervention required to prevent permanent impairment/damage: | 1 |
Side-effect | Case number |
---|---|
ATRIAL FIBRILLATION | 1 |
HYPERHIDROSIS | 1 |
FEBRILE NEUTROPENIA | 1 |
DYSPNOEA | 1 |
DRUG INTERACTION | 1 |
DIARRHOEA | 1 |
DEPRESSION | 1 |
CIRCULATORY COLLAPSE | 1 |
CHEST PAIN | 1 |
BONE PAIN | 1 |
HYPOKINESIA | 1 |
ASTHENIA | 1 |
ARRHYTHMIA SUPRAVENTRICULAR | 1 |
ANTICONVULSANT DRUG LEVEL INCREASED | 1 |
ALCOHOL ABUSE | 1 |
Adverse drug reaction | 1 |
ACUTE MYOCARDIAL INFARCTION | 1 |
ABORTION INDUCED | 1 |
ABDOMINAL PAIN | 1 |
PALPITATIONS | 1 |
UTERINE CONTRACTIONS DURING PREGNANCY | 1 |
TREMOR | 1 |
SUICIDAL IDEATION | 1 |
STRESS CARDIOMYOPATHY | 1 |
RASH MACULO-PAPULAR | 1 |
PULMONARY OEDEMA | 1 |
Product name confusion | 1 |
PNEUMONIA | 1 |
PARAESTHESIA | 1 |
Wrong drug | 1 |
OVERDOSE | 1 |
NEUTROPENIC SEPSIS | 1 |
MUCOSAL INFLAMMATION | 1 |
LUNG CONSOLIDATION | 1 |
LIP SWELLING | 1 |
Intercepted product prescribing error | 1 |
INFECTION | 1 |
HYPOTENSION | 1 |
Target UniProtKB ID | Activity in nm | Target Name | Target gene |
---|---|---|---|
P07550 | 501.19 | Beta-2 adrenergic receptor | ADRB2_HUMAN |
Toxicity class: | 5 |
---|---|
Toxicity type: | cardiovascular |
LD50: | 3370 mg/kg |
ChEBML: | CHEMBL776 |
---|---|
DrugBank: | DB00816 |